Description

M617 is a selective galanin receptor 1 (GAL1) agonist, with Kis of 0.23 and 5.71 nM for GAL1 and GAL2, respectively. M617, acting through its central GAL1, can promote GLUT4 expression and enhance GLUT4 content in the cardiac muscle of type 2 diabetic rats[1][2].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–Neuroscience-Neuromodulation–C112H161N29O28—-[1]Lundström, L., et al. A Galanin Receptor Subtype 1 Specific Agonist. Int J Pept Res Ther 11, 17–27 (2005).|[2]Fang P, et al. Central injection of GalR1 agonist M617 facilitates GLUT4 expression in cardiac muscle of type 2 diabetic rats. Exp Gerontol. 2015;65:85-89.–860790-38-1–2361.65–99.54–C([C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N[C@H](C(NCC(=O)N2[C@H](C(N[C@H](C(=O)N3[C@H](C(=O)N4[C@H](C(NCC(N[C@@H](CC5=CC=CC=C5)C(N[C@H](C(=O)N6[C@H](C(N[C@@H](CC7=CC=CC=C7)C(N[C@@H](CCCNC(=N)N)C(N)=O)=O)=O)CCC6)CO)=O)=O)=O)CCC4)CCC3)CCC(N)=O)=O)CCC2)=O)CC(C)C)=O)CC(C)C)=O)=O)=O)C)=O)CO)=O)CC(N)=O)=O)CC(C)C)=O)[C@@H](C)O)=O)NC(CN)=O)C=8C=9C(NC8)=CC=CC9–Cardiovascular Disease–DMSO : 100 mg/mL (ultrasonic)–Neuropeptide Y Receptor—-GPCR/G Protein;Neuronal Signaling–Peptides